KFDA approves cervical cancer vaccine Gardasil

Published: 2007-07-02 06:56:00
Updated: 2007-07-02 06:56:00
Korea people are delighted to hear that a vaccine against cervical cancer will be marketed, possibly in September or October.

The Korea Food and Drug Administration (KFDA) approved on June 27 the sale of Gardasil, manufactured by the U.S. pharmaceutical company Merck, following its approval on...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.